VRK2 and neoplasm: We next used Celligner, which integrates RNA-sequencing data from The Cancer Genome Atlas (TCGA), Treehouse Childhood Cancer Initiative (Treehouse), and Office of Cancer Genomics Therapeutically Applicable Research to Generate Effective Treatments (TARGET) human tumor-sequencing studies, to identify whether low VRK2 expression correlates with nervous system lineage cancers (10).